Remdesivir is used for the treatment of COVID-19 and is approved by the Food and Drug Administration (FDA). It is being manufactured by seven Indian companies. The sudden spike in the number of cases has resulted in the increased demand for the drug. The second wave of the virus has resulted in a huge number of hospitalization of patients who are now in severe need of the vaccine. The production rate is slower compared to the high rising demand.
Apart from this, another factor contributing to the shortage of the drug is the black marketing of the vaccine. Illegal sale of vaccine from unauthorized bodies quoting a high price of 50,000 is also being reported in several states. Several people such as medical staff, pharmacy owners, and so on have been arrested for this.